Open Access
Interferon plus ribavirin and interferon alone in preventing hepatocellular carcinoma: A prospective study on patients with HCV related cirrhosis
World Journal Of GastroenterologyPeer ReviewedAzzaroli Francesco2004Journals
To determine the role of interferon (IFN) with or without ribavirin in preventing or delaying hepatocellular carcinoma (HCC) development in patients with hepatitis C virus (HCV) related cirrhosis. Data on the preventive effect of IFN plus ribavirin treatment are lacking.

The content you want is available to Zendy users.

Already have an account? Sign in
Having issues? Contact support